US2019112665A1PendingUtilityA1
Compositions and methods for prognosis of ovarian cancer
Est. expiryJun 17, 2028(~1.9 yrs left)· nominal 20-yr term from priority
C12Q 2600/178C12Q 2600/106C12Q 2600/112A61K 31/713A61K 45/00C12Q 2600/16A61P 35/00C12Q 2600/118C12Q 1/6886
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
Claims
exact text as granted — not AI-modified1 . A method of determining the prognosis of ovarian cancer in a subject comprising:
(a) obtaining a biological sample from the subject; (b) determining the expression level in said sample of a nucleic acid sequence selected from the group consisting of SEQ ID NOS: 1-71 and sequences at least about 80% identical thereto; and (c) comparing said expression level to a threshold expression level,
wherein comparison of said expression level of said nucleic acids to said threshold expression level is predictive of the prognosis of said ovarian-cancer subject.
2 .- 44 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.